{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:10:36Z","timestamp":1750824636380,"version":"3.41.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["800176"],"award-info":[{"award-number":["800176"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec016\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>In a vaccine trial conducted between 2019 and 2022 in Boende, a remote, resource-constrained area of the Democratic Republic of the Congo, our research team developed an ancillary care (AC) policy to provide adequate care and follow-up for concomitant adverse events (AE), whether study-related or not. The trial aimed to assess the safety and immunogenicity of an Ebola vaccine regimen among approximately 700 healthcare providers and frontliners to strengthen outbreak preparedness in this Ebola-endemic region, where access to healthcare is severely limited by poverty, weak infrastructure, and an overstretched health system.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec017\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A mixed-methods approach was used to assess participants\u2019 acceptability of the AC policy. First, participants with AE completed a questionnaire (1-\u20135 scale; 6 questions on AC policy support, 4 on the consequences of no support, and an open comment field). Second, a telephone survey (1-\u20133 scale; 3 questions evaluating the AC policy, 1 on unsupported AE and an open comment field) was conducted with participants, both with and without AE. Descriptive statistics were used for quantitative data analysis, while open comments were coded qualitatively. Third, semi-structured interviews were conducted with participants who experienced a (serious) AE and either benefited from or did not benefit from the policy. Participants were selected using purposive and convenience sampling, and thematic analysis was performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec018\">\n<jats:title>Results<\/jats:title>\n<jats:p>Of 185 individuals with AE, 290 surveys were collected, with 93.5% expressing (very) strong appreciation for the AC policy. In the telephone survey, all 311 respondents supported the AC policy and emphasized its importance, 88.1% indicated it addressed their medical needs, and 35.7% reported experiencing an AE not covered by the policy. The 17 interviews revealed three major themes: 1) Experiences with AE management and AC support; 2) Financial impact of (non-) support; 3) Expectations of AC support. Participants who received AC reported personal, medical, and financial benefits, but noted limitations, such as the scope and duration of support, variations in local healthcare practices, and administrative hurdles.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec019\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Both quantitative and qualitative findings show high endorsement for the AC policy support, regardless of participants\u2019 personal use. This acceptability study highlights the importance of AC in clinical trials and comprehensive participant care in research.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0325435","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:33:28Z","timestamp":1750786408000},"page":"e0325435","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cWe have to amplify what we saw at EBOVAC\u201d \u2013 Assessing participant perceptions, attitudes, and acceptability of an ancillary care policy in an Ebola vaccine trial in the Democratic Republic of the Congo: A mixed methods study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2879-5330","authenticated-orcid":true,"given":"Gwen","family":"Lemey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ynke","family":"Larivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Milolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tr\u00e9sor","family":"Zola Matuvanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Salloum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Mitashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Ravinetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Van geertruyden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hypolite","family":"Muhindo-Mavoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivi","family":"Maketa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibyl","family":"Anthierens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"pone.0325435.ref001","author":"Innovative Medicines Initiative","year":"2024"},{"issue":"9","key":"pone.0325435.ref002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046835","article-title":"Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol","volume":"11","author":"Y Larivi\u00e8re","year":"2021","journal-title":"BMJ Open"},{"key":"pone.0325435.ref003","article-title":"Rapport du Coordinateur Humanitaire sur l\u2019utilisation des subventions du CERF","volume-title":"R\u00e9publique D\u00e9mocratique du Congo","author":"United Nations Central Emergency Response Fund","year":"2014"},{"key":"pone.0325435.ref004","volume-title":"Congo, Dem. Rep","author":"World Bank","year":"2024"},{"key":"pone.0325435.ref005","volume-title":"Plan National de D\u00e9veloppement Sanitaire recadr\u00e9 pour la p\u00e9riode 2019-2022","author":"Minist\u00e8re de la Sant\u00e9 de la R\u00e9publique D\u00e9mocratique du Congo","year":"2018"},{"issue":"7","key":"pone.0325435.ref006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060036","article-title":"Evaluation of needs and supply of emergency care in Kinshasa, Democratic Republic of Congo: a cross-sectional household survey","volume":"12","author":"K Diango","year":"2022","journal-title":"BMJ Open"},{"key":"pone.0325435.ref007","author":"Council for International Organizations of Medical Sciences","year":"2021"},{"key":"pone.0325435.ref008","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s002280050364","article-title":"Adverse events and discomfort in studies on healthy subjects: the volunteer\u2019s perspective. A survey conducted by the German Association for Applied Human Pharmacology","volume":"53","author":"R Hermann","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"pone.0325435.ref009","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/phe\/pht015","article-title":"Ancillary Care: From Theory to Practice in International Clinical Research","volume":"6","author":"B Pratt","year":"2013","journal-title":"Public Health Ethics"},{"issue":"7454","key":"pone.0325435.ref010","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/bmj.328.7454.1494","article-title":"Medical researchers\u2019 ancillary clinical care responsibilities","volume":"328","author":"L Belsky","year":"2004","journal-title":"BMJ"},{"issue":"6","key":"pone.0325435.ref011","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005726","article-title":"Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo","volume":"6","author":"G Lemey","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"1","key":"pone.0325435.ref012","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/17470161231194139","article-title":"Researchers\u2019 responsibilities in resource-constrained settings: experiences of implementing an ancillary care policy in a vaccine trial in the Democratic Republic of the Congo","volume":"20","author":"G Lemey","year":"2023","journal-title":"Research Ethics"},{"issue":"6","key":"pone.0325435.ref013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015259","article-title":"An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations","volume":"9","author":"G Lemey","year":"2024","journal-title":"BMJ Glob Health"},{"key":"pone.0325435.ref014","volume-title":"The community health system in the DRC: An overview","author":"Frontline Health Project","year":"2020"},{"issue":"2","key":"pone.0325435.ref015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/2159676X.2019.1704846","article-title":"To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales","volume":"13","author":"V Braun","year":"2019","journal-title":"Qualitative Research in Sport, Exercise and Health"},{"issue":"1","key":"pone.0325435.ref016","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12874-018-0594-7","article-title":"Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period","volume":"18","author":"K Vasileiou","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"pone.0325435.ref017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","article-title":"One size fits all? What counts as quality practice in (reflexive) thematic analysis?","volume":"18","author":"V Braun","year":"2020","journal-title":"Qualitative Research in Psychology"},{"issue":"1","key":"pone.0325435.ref018","first-page":"1","article-title":"Toward good practice in thematic analysis: Avoiding common problems and be(com)ing a knowing researcher","volume":"24","author":"V Braun","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"1","key":"pone.0325435.ref019","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12910-023-00889-x","article-title":"\u2018Guidance should have been there 15 years ago\u2019 research stakeholders\u2019 perspectives on ancillary care in the global south: a case study of Malawi","volume":"24","author":"BM Kapumba","year":"2023","journal-title":"BMC Medical Ethics"},{"key":"pone.0325435.ref020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1747-5341-7-7","article-title":"Forms of benefit sharing in global health research undertaken in resource poor settings: a qualitative study of stakeholders\u2019 views in Kenya","volume":"7","author":"GM Lairumbi","year":"2012","journal-title":"Philos Ethics Humanit Med"},{"issue":"4","key":"pone.0325435.ref021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/medethics-2012-100936","article-title":"Ethics of medical care and clinical research: a qualitative study of principal investigators in biomedical HIV prevention research","volume":"39","author":"BG Haire","year":"2013","journal-title":"J Med Ethics"},{"key":"pone.0325435.ref022","doi-asserted-by":"crossref","first-page":"164","DOI":"10.12688\/wellcomeopenres.16858.1","article-title":"What do we know about ancillary care practices in East and Southern Africa? A systematic review and meta-synthesis","volume":"6","author":"BM Kapumba","year":"2021","journal-title":"Wellcome Open Res"},{"issue":"4","key":"pone.0325435.ref023","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jme.2007.020461","article-title":"Malawians permit research bronchoscopy due to perceived need for healthcare","volume":"34","author":"N Mtunthama","year":"2008","journal-title":"J Med Ethics"},{"issue":"3","key":"pone.0325435.ref024","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cct.2010.12.003","article-title":"More than the money: a review of the literature examining healthy volunteer motivations","volume":"32","author":"L Stunkel","year":"2011","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"pone.0325435.ref025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4269\/ajtmh.23-0581","article-title":"Healthcare Providers\u2019 and Frontline Workers\u2019 Experiences of an Ebola Vaccine Trial in the Boende Health District of the Democratic Republic of the Congo","volume":"111","author":"T Zola Matuvanga","year":"2024","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0325435.ref026","doi-asserted-by":"crossref","first-page":"115833","DOI":"10.1016\/j.socscimed.2023.115833","article-title":"Protection, health seeking, or a laissez-passer: Participants\u2019 decision-making in an EVD vaccine trial in the eastern Democratic Republic of the Congo","volume":"323","author":"M James","year":"2023","journal-title":"Soc Sci Med"},{"issue":"2","key":"pone.0325435.ref027","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/dewb.12090","article-title":"The Challenges of Research Informed Consent in Socio-Economically Vulnerable Populations: A Viewpoint From the Democratic Republic of Congo","volume":"16","author":"M Kalabuanga","year":"2016","journal-title":"Dev World Bioeth"},{"issue":"2","key":"pone.0325435.ref028","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.clpt.6100192","article-title":"Balancing justice and autonomy in clinical research with healthy volunteers","volume":"82","author":"NE Kass","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"pone.0325435.ref029","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1467-8519.2012.01972.x","article-title":"Misconceptions about coercion and undue influence: reflections on the views of IRB members","volume":"27","author":"E Largent","year":"2013","journal-title":"Bioethics"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:33:40Z","timestamp":1750786420000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325435"}},"subtitle":[],"editor":[{"given":"Omar Enzo","family":"Santangelo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325435","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}